MEDICLIN AG — M&A Activity 2001

Dec 5, 2001

News Details

Corporate | 5 December 2001 11:11

Mediclin AG english

Supervisory Board approves acquisition Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Supervisory Board approves acquisition – Sales and results for 2001 within the target corridor – Further strong growth expected for 2002 – No sale of shares planned after the lock up period Frankfurt, 5 December 2001. The Supervisory Board of MediClin AG, one of the leading clinic operators in Germany, approved an extensive investment budget concerning future growth of the corporation at its meeting yesterday. This also includes two imminent acquisitions which would contribute significantly to group sales next year. Both facilities are operating profitably. Following consultation with the shareholders, who approved a 12-months-lock up period within the context of the IPO (December 6, 2000), the company announced that it has no intention to sell any shares in the medium term. The board as well as the shareholders are convinced that the privatisation process of clinics will continue to increase dramatically and that MediClin will have an above proportionate share in this growth market. About MediClin AG MediClin AG is a nation-wide clinic operator with head office in Frankfurt. The administrative headquarters of 42 clinics and facilities are domiciled in Offenburg. The MediClin facilities are distributed ovaer 33 locations in 11 federal states and have a total capacity of over 8,700 beds. They include general hospitals, special treatment facilities, specialised hospitals, clinics for medical rehabilitation/subsequent nursing treatment and nursing facilities. Two facilities are run in the form of management agreements; MediClin employs more than 9,000 people of whom over 700 are physicians in various specialist fields. For more information please contact: MediClin AG Investor Relations Alexandra Mühr Wilhelm-Leuschner-Straße 9-11 60329 Frankfurt am Main Tel.: (069) 25 60 02-13 e-Mail: alexandra.muehr@mediclin.de http://www.mediclin.de end of message, (c)DGAP 05.12.2001